drugset / Trial / NCT00675623
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The Connection Study is a six-month confirmatory Phase 3 study to determine the safety and efficacy of Dimebon in the treatment of mild-to-moderate Alzheimer's disease (AD).
Timeline
- Start
- 2008-05
- Primary completion
- 2009-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latrepirdine | Small molecule | 5 mg | Oral |
| Subject | Latrepirdine | Small molecule | 20 mg | Oral |